None of our melanoma specimens analysed, including those from the responding patient, contained genomic mutations of c-kit in exon 9 or 11, which is frequently mutated in imatinib-responsive gastrointestinal stromal tumours (Heinrich et al, 2003). Here, KIT is linked to gastrointestinal stromal tumor.